Clear Search

Books+ Search Results

Subject (Genre): Is
Is Is Not
Legislative hearings
Subject with Hierarchy: Is
Is Is Not
Pharmaceutical industry
Subject: Is
Is Is Not
Competition

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (7)
1.
The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183063
Location
Yale Internet Resource >> None
Format
Books / Online
2.
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo153433
Location
Yale Internet Resource >> None
Format
Books / Online
3.
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-17
Format
Books
4.
Competition in the pharmaceutical supply chain : the proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:115-28
Format
Books
5.
Competition in the pharmaceutical supply chain : the proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
PDF version
Text version
Location
Yale Internet Resource >> None
Format
Books / Online
6.
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
https://purl.fdlp.gov/GPO/gpo113215
Location
Yale Internet Resource >> None
Format
Books / Online
7.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Author
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:115-33
Format
Books
8.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Author
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo86757
Location
Yale Internet Resource >> None
Format
Books / Online
9.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo77020
Location
Yale Internet Resource >> None
Format
Books / Online
10.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:114-97
Format
Books
11.
Pay-for-delay deals : limiting competition and costing consumers : hearing before the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Committee on the Judiciary, United States Senate, One Hundred Thirteenth Congress, first session, July 23, 2013
Author
United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Competition Policy, and Consumer Rights, author
Published
Washington : U.S. Government Printing Office, 2013.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/2:S.HRG.113-279
Format
Books
12.
Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington, DC : U.S.Government Printing Office, 2002.
Online
https://purl.fdlp.gov/GPO/gpo89001
Location
Yale Internet Resource >> None
Format
Books / Online